BCL2L11 and acute myeloid leukemia: Of note, loss of Bim, Puma, Noxa, Bmf, or combinations thereof, made no significant difference to the kinetics of morbidity (Figure 1 and Supplementary Figure S1), all recipients developing florid AML within 30–65 days.